Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Advanced synthesis of 5-biphenyl-4-ylmethylpyrrolidin-2-one via patent CN101631765B. Enhances purity and supply chain stability for pharmaceutical intermediates manufacturing.
Advanced synthesis of high-purity butylphthalide via safe aqueous reduction and vacuum distillation. Ideal for reliable pharma intermediate supply chains.
Patent CN120923476A reveals a 2-step Ni-catalyzed route for Orforglipron intermediates, eliminating SFC resolution and enabling cost-effective manufacturing.
Patent CN109320461B details a novel route for 2-n-propyl-4-methyl-6-carboxybenzimidazole, offering superior purity and cost reduction in API manufacturing.
Patent CN110257351A reveals high-activity enzyme mutants for chiral alcohol synthesis offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112481226B details solvent-tolerant ADH mutants for scalable production of chiral alcohols, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN105131015B reveals a green solid acid method for 7-AVCA. This offers cost reduction and supply chain reliability for antibiotic manufacturers.
Novel synthesis of 1,3-disubstituted pyrazoles as AR antagonists. Efficient route for pharma intermediates with scalable steps and high purity.
Patent CN115677559A reveals a one-step microwave synthesis for tetrahydrocarbazolone, offering significant cost reduction and high purity for pharmaceutical supply chains.
Patent CN106866466B details SO3 sulfonation for high-purity intermediates. This method reduces waste acid and ensures supply chain stability for global buyers.
Patent CN115677559A reveals a microwave-assisted one-step synthesis for high-purity ondansetron intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel one-step method using benzamide and tert-butyl isocyanide offers high yields and simplified purification for reliable guanidine compound supply chains.
Patent CN1118476C details a facile two-step synthesis of HIV protease inhibitors from mannose dilactone, offering cost reduction and scalability for pharmaceutical intermediates.
Novel synthesis route for monocyclic beta-lactam compounds offering cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Novel Ni-catalyzed route for latanoprost intermediate ensures significant cost reduction and enhanced supply reliability for global pharmaceutical manufacturing partners seeking scalable solutions.
Advanced synthesis of Vitamin B1 intermediate via patent CN102712602B. High yield, mild conditions, reliable supply chain for pharmaceutical manufacturing.
Patent CN116179502A details a novel ketoreductase mutant enabling >99% ee chiral alcohol synthesis. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Novel photochemical method for dimethylisobenzofuranone offers green synthesis and supply chain stability for pharmaceutical intermediate manufacturing partners.
Patent CN118561689A reveals a novel esterification method yielding >99% purity. This process eliminates column chromatography, ensuring cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN103923110A details high-yield synthesis of antibacterial benzimidazole metal complexes. Offers cost reduction and scalable supply for fine chemical manufacturing.